4C Medical Technologies

4C Medical Technologies, Inc.

80 Investors

Minimally Invasive Heart Therapies

Maple Grove, MN

4C Medical Technologies, Inc. is a pioneering medical device company that specializes in developing innovative minimally invasive therapies for structural heart disease. The company''s flagship focus is on treating mitral regurgitation (MR), a condition that affects heart function and can lead to severe complications if untreated.

Products & Team

AltaValve

Medical DeviceSeed

The AltaValve is an advanced transcatheter mitral valve replacement (TMVR) device designed specifically for patients suffering from mitral regurgitation. This innovative technology addresses the needs of patients who are not suitable candidates for traditional open-heart surgery, providing a crucial alternative therapy to manage their condition effectively.

Value Proposition

The AltaValve solves the urgent problem of creating a viable treatment pathway for patients with moderate to severe mitral regurgitation who cannot undergo conventional surgical methods, improving their quality of life and reducing health risks.

Pain Points

The primary pain points addressed include the high surgical risk for these patients, lack of effective non-surgical options, and the need for innovative solutions to manage well-being when conventional procedures are ruled out.

Supra-annular positioning in the left atrium which enhances valve performanceAtrial-only fixation that preserves the integrity of the native mitral valve and left ventricleDesigned to mitigate complications associated with the complexities of the mitral annulusFlexible delivery options via either transapical or transseptal approaches